Associations of a polygenic risk score with coronary artery disease phenotypes in the Prospective Multicenter Imaging Study for Evaluation of Chest Pain (PROMISE) trial
- 21 May 2022
- journal article
- research article
- Published by Elsevier in American Heart Journal
- Vol. 252, 12-15
Abstract
No abstract availableKeywords
This publication has 10 references indexed in Scilit:
- Polygenic Risk Score–Enhanced Risk Stratification of Coronary Artery Disease in Patients With Stable Chest PainCirculation: Genomic and Precision Medicine, 2021
- Polygenic Scores to Assess Atherosclerotic Cardiovascular Disease RiskCirculation Research, 2020
- Genetic Risk of Coronary Artery Disease, Features of Atherosclerosis, and Coronary Plaque BurdenJournal of the American Heart Association, 2020
- Genome-wide polygenic scores for common diseases identify individuals with risk equivalent to monogenic mutationsNature Genetics, 2018
- Central Core Laboratory versus Site Interpretation of Coronary CT Angiography: Agreement and Association with Cardiovascular Events in the PROMISE TrialRadiology, 2018
- Use of High-Risk Coronary Atherosclerotic Plaque Detection for Risk Stratification of Patients With Stable Chest PainJAMA Cardiology, 2018
- An age- and sex-specific gene expression score is associated with revascularization and coronary artery disease: Insights from the Prospective Multicenter Imaging Study for Evaluation of Chest Pain (PROMISE) trialAmerican Heart Journal, 2017
- Modeling Linkage Disequilibrium Increases Accuracy of Polygenic Risk ScoresThe American Journal of Human Genetics, 2015
- A comprehensive 1000 Genomes–based genome-wide association meta-analysis of coronary artery diseaseNature Genetics, 2015
- Outcomes of Anatomical versus Functional Testing for Coronary Artery DiseaseNew England Journal of Medicine, 2015